Longevity medicine and aging research involve the study of biological processes that lead to aging with the goal of developing interventions to extend human lifespan or improve healthspan.
Extending lifespan and improving healthspan by addressing the underlying biological mechanisms of aging.
Research focuses on understanding age-related molecular and cellular changes, such as senescence in cells (senolytics), telomere shortening, and mitochondrial dysfunction. Interventions include pharmacological treatments, gene therapies, and lifestyle modifications aimed at slowing down these processes.
Research-driven with limited manufacturing infrastructure; primarily lab-based.
Involves extensive preclinical testing in cell cultures and animal models before moving to human clinical trials. Development timelines are long, often taking years or decades due to regulatory hurdles and complexity of the biological systems involved.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.